Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Comparison of the Revised 4 Th (2016) and 5 Th (2022) Editions of the World Health Organization (WHO) Classification in a Cohort of Patients with Lower-Risk Myelodysplastic Syndromes/Neoplasms (MDS) - a Glam Registry (REGLAM) Analysis

Blood (2023) 142 (Supplement 1): 5179.

https://doi.org/10.1182/blood-2023-185122

Published: 2023

Journal Articles

Ten Years of Hematopoietic Stem Cell Transplantation in Patients with Light Chain Amyloidosis: Real World Data from a Health Center in Latin America

Gisela Bendelman, Erika Barbara Brulc, Maria Adela Aguirre, Elsa Mercedes Nucifora, María Agustina Marco, Maria Lourdes Posadas, Jorge Arbelbide, Valeria Ziegler, Marcelina Carretero

Blood (2023) 142 (Supplement 1): 6697.

https://doi.org/10.1182/blood-2023-188895

Published: 2023

Journal Articles

Non-Shelterin Telomere Genes Deregulation in Plasma Cell Disorders

Julieta Panero, MSc, Dorotea Beatriz Fantl, MD, Jorge Arbelbide, MD, Irma Slavutsky

Blood (2014) 124 (21): 2020.

https://doi.org/10.1182/blood.V124.21.2020.2020

Published: 2014

Journal Articles

Clinical Characteristics and Prognosis in South-American Patients with Myelodysplastic Syndrome: A Multicenter Study

Carolina Belli, PhD, Ronald Feitosa Pinheiro, MD PhD, Maria Gabriela Flores, MD, Silvia M. M. Magalhaes, MD, Laura Kornblihtt, MD PhD, Alicia Enrico, MD, Juliana Cordeiro, Ana Lisa Basquiera, MD, Marcela Cavalcante de Andrade Silva, Roberta da Silva Tanizawa, Noemi Pintos, MD, Graciela Alfonso, MD, Jorge Arbelbide, MD, Francisco Sakamoto, MD, Nora Watman, MD, Ximena Valladares Ticona, Irene B Larripa, PhD, Soledad S. Undurraga, MD, Elvira RP Velloso, MD PhD

Blood (2014) 124 (21): 4651.

https://doi.org/10.1182/blood.V124.21.4651.4651

Published: 2014

Journal Articles

Is Not Age, But Comorbidities. Allogeneic Hematopoietic Stem Cell Transplantation In Patients Older Than 50 Years In Argentina

Mariano Berro, MD, Juan Garcia, MD, Ana Basquiera, MD, Maria Marta Rivas, MD, Maria Cecilia Foncuberta, MD, Ruben Burgos, MD, Gregorio Jaimovich, Vera Milovic, Juliana Martinez Rolon, MD, Guillermina Remaggi, PhD, Jorge Arbelbide, MD, Jorge H Milone, Sebastian Yantorno, Gustavo Jarchum, MD, Maria Sol Jarchum, G Caeiro, Gustavo Daniel Kusminsky, MD

Blood (2013) 122 (21): 5467.

https://doi.org/10.1182/blood.V122.21.5467.5467

Published: 2013

Journal Articles

Allogeneic Stem Cell Transplantation With Reduced Intensity Conditioning Regimen In Patients With Relapsed Hodgkin´s Lymphoma

Maria Marta Rivas, MD, Mariano Berro, MD, Sebastian Yantorno, MD, Maria Virginia Prates, MD, Jorge H Milone, Ana Lisa Basquiera, Adriana Berreta, MD, Juan Garcia, MD, Guillermina Remaggi, MD, Juliana Martinez Rolon, MD, Jorge Arbelbide, MD, Monica Makiya, MD, Eduardo Dibar, Alejandro Requejo, MD, Leonardo Julio Feldman, Sr., MD, Vera Milovic, Maria Cecilia Foncuberta, MD, Rubén Burgos, MD, Gustavo Daniel Kusminsky, MD

Blood (2013) 122 (21): 5511.

https://doi.org/10.1182/blood.V122.21.5511.5511

Published: 2013

Journal Articles

Rituximab Treatment for Autoinmune Hemolitic Diseases,

Natalia Schutz, MD,, Jorge Arbelbide, MD, Walter Skordo, MD, Susana Viñuales, MD, Elsa Nucifora, MD, Dorotea Beatriz Fantl, MD

Blood (2011) 118 (21): 3168.

https://doi.org/10.1182/blood.V118.21.3168.3168

Published: 2011

Journal Articles

Cytogenetic Features and Prognosis In Argentinean Patients with Myelodysplastic Syndrome: a Multicenter Study

Carolina Belli, PhD, Raquel Bengió, MD, Pedro Negri Aranguren, MD, Francisco Sakamoto, MD, María Gabriela Flores, MD, Nora Watman, MD, Elsa Nucifora, MD, Jorge Arbelbide, MD, María Virginia Prates, MD, Irene B Larripa, PhD

Blood (2010) 116 (21): 1888.

https://doi.org/10.1182/blood.V116.21.1888.1888

Published: 2010

Journal Articles

Decitabine Activity in Myelodysplastic Syndromes. International Cooperative Multi-Center Study.

Marcelo Iastrebner, MD, Jun Ho Jang, Elsa Nucifora, MD, Kihyun Kim, M.D., Federico Sackmann, Dong Hwan (Dennis) Kim, Sergio Orlando, Chul Won Jung, Ana Basquiera, MD, Raquel Bengio, Luis Quiroga, MD, Graciela Klein, MD, Juan Garcia, MD, Jorge Arbelbide, Astrid Pavlovsky, Maria Virginia Prates

Blood (2009) 114 (22): 3804.

https://doi.org/10.1182/blood.V114.22.3804.3804

Published: 2009

Journal Articles

Applicability of a New Prognostic Scoring System in Myelodysplastic Syndromes. MDS Study Group of Hematology.

Gabriela Flores, Maria Isabel Santos, MD, Graciela Alfonso, MD, Maria Cabrejo, Maria Virginia Prates, Marcelo Iastrebner, MD, Dorotea Beatriz Fantl, MD, Jorge Arbelbide, Reinaldo Campestri, MD, Diana Penchasky, MD, Paula Cardenas, MD, Federico Sackmann, Juan Garcia, MD, Elsa Nucifora, MD, Ana Basquiera, Astrid Pavlovsky, Miguel Arturo Pavlovsky, Isolda Fernandez, Susana Viñuales, MD

Blood (2009) 114 (22): 4838.

https://doi.org/10.1182/blood.V114.22.4838.4838

Published: 2009

Journal Articles

Secondary Myelodysplastic Syndrome.(sMDS) Presentation and Evolution.

Laura Kornblihtt, Alicia Enrico, Jorge Milone, Maria Virginia Prates, Carolina B Belli, Jorge Arbelbide, Diana Lafalce, MD, Diana Penchasky, MD, Dorotea Fantl, MD, Maria Marta Rivas, MS, PhD, Maria Cabrejo, Maria Caicedo

Blood (2009) 114 (22): 4850.

https://doi.org/10.1182/blood.V114.22.4850.4850

Published: 2009

Journal Articles

Analysis of Telomeric Proteins Expression in Plasma Cell Disorders

Julieta Panero, MSc, Dorotea Beatriz Fantl, MD, Jorge Arbelbide, MD, Irma Slavutsky, MD, PhD

Blood (2008) 112 (11): 2719.

https://doi.org/10.1182/blood.V112.11.2719.2719

Published: 2008

Journal Articles

Decitabine in Myelodysplastic Syndromes: Argentine Initial Multi-Institutional Clinical Experience

Marcelo Iastrebner, MD, Virginia Prates, MD, Jorge Arbelbide, MD, Isolda Fernandez, MD, Gabriela Flores, MD, Gustavo Milone, MD, Federico Sackmann, MD, Silvia Saba, MD, Sergio Orlando, MD, Alfredo Basso, MD, Astrid Pavlovsky, MD, Gustavo Taborda, MD, Jorge Korin, MD, Julio Pose, MD

Blood (2008) 112 (11): 5086.

https://doi.org/10.1182/blood.V112.11.5086.5086

Published: 2008

Journal Articles

Aberrant Gene Promoter Methylation of Tumor Suppressor Genes in Plasma Cell Disorders.

Carmen Stanganelli, MSc, Jorge Arbelbide, MD, Juliana Zimerman, MD, Dorotea Beatriz Fantl, MD, Claudia Corrado, MD, Irma Slavutsky, PhD

Blood (2007) 110 (11): 2487.

https://doi.org/10.1182/blood.V110.11.2487.2487

Published: 2007

Journal Articles

Evaluation of Microsatellite Instability and Loss of Heterozygosity in Defining the Instability Phenotype of Myelodysplastic Syndromes.

Maria Lorena Vazquez, MS, Jorge Arbelbide, MD, Dorotea Beatriz Fantl, MD, Elsa Nucifora, MD, Irene Larripa, PhD, Ariela Fundia, PhD

Blood (2007) 110 (11): 4620.

https://doi.org/10.1182/blood.V110.11.4620.4620

Published: 2007

NARROW

Comparison of the Revised 4 Th (2016) and 5 Th (2022) Editions of the World Health Organization (WHO) Classification in a Cohort of Patients with Lower-Risk Myelodysplastic Syndromes/Neoplasms (MDS) - a Glam Registry (REGLAM) Analysis

Ten Years of Hematopoietic Stem Cell Transplantation in Patients with Light Chain Amyloidosis: Real World Data from a Health Center in Latin America

Non-Shelterin Telomere Genes Deregulation in Plasma Cell Disorders

Clinical Characteristics and Prognosis in South-American Patients with Myelodysplastic Syndrome: A Multicenter Study

Is Not Age, But Comorbidities. Allogeneic Hematopoietic Stem Cell Transplantation In Patients Older Than 50 Years In Argentina

Allogeneic Stem Cell Transplantation With Reduced Intensity Conditioning Regimen In Patients With Relapsed Hodgkin´s Lymphoma

Rituximab Treatment for Autoinmune Hemolitic Diseases,

Cytogenetic Features and Prognosis In Argentinean Patients with Myelodysplastic Syndrome: a Multicenter Study

Decitabine Activity in Myelodysplastic Syndromes. International Cooperative Multi-Center Study.

Applicability of a New Prognostic Scoring System in Myelodysplastic Syndromes. MDS Study Group of Hematology.

Secondary Myelodysplastic Syndrome.(sMDS) Presentation and Evolution.

Analysis of Telomeric Proteins Expression in Plasma Cell Disorders

Decitabine in Myelodysplastic Syndromes: Argentine Initial Multi-Institutional Clinical Experience

Aberrant Gene Promoter Methylation of Tumor Suppressor Genes in Plasma Cell Disorders.

Evaluation of Microsatellite Instability and Loss of Heterozygosity in Defining the Instability Phenotype of Myelodysplastic Syndromes.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only